Programming - Hypertension Scientific Sessions

Save the date!
October 7-11, 2026
Hyatt Regency Crystal City | Arlington, Virginia

Hypertension 2026 Schedule-at-a-Glance

Wednesday, Oct. 7 Activities
Time Activity
7:00 pm to 9:00 pm Opening Member Reception and Networking Session
(Free to attend, but please add a ticket to registration)
Thursday, Oct. 8 Activities
Time Activity
7:30 am to 9:00 am

Session 1
Welcome Remarks and Keynotes

American Heart Association Presidential Remarks
Manesh Patel, MD, FAHA

Welcome Remarks
Jane F. Reckelhoff, PhD, FAHA | Chair, Council on Hypertension
Steven D. Crowley, MD | Chair, Hypertension 2026 Scientific Sessions Program Committee

Metabolic Reprogramming via HIF-1α to Confront Kidney and Cardiovascular Disease
Volker Haase, MD

HIF-2α inhibition and Pheochromocytoma/Paraglioma
Camilo Jimenez Vasquez, MD
9:00 am to 10:00 am

Session 2
Aldosterone: Biology and Recent Clinical Trials

Recent Clinical Trials
Jamie Dwyer, MD

Mechanisms for disrupting aldosterone signals to afford protection in hypertension and CVD
David Ellison, MD
10:00 am to 10:30 am Networking Event: Meet the Keynote Speakers
(limited attendance)
Coffee and snacks will be served
10:00 am to 10:30 am Break
10:30 am to 11:00 am Session 3
The Donald Seldin Lecture
11:00 am to 12:00 pm

Session 4
Concurrent Sessions A, B and C
(Oral Abstract Presentations)
12:00 pm to 1:30 pm

Lunch On Your Own
12:15 pm to 12:35 pm Sponsored Learning Studio
Astra Zeneca Pharmaceuticals
1:00 pm to 1:30 pm Sponsored Learning Studio
ReCor Medical
1:30 pm to 2:00 pm

Session 5
Harriet Dustan Award Lecture
2:00 pm to 3:00 pm

Session 6
Macula Densa

Imaging macula densa function in blood pressure regulation
Janos Peti-Peterdi, MD, PhD

The macula densa’s role in mechanisms of AKI and resulting CKD
Ruisheng Liu, MD, PhD
3:00 pm to 3:30 pm Break
3:30 pm to 5:30 pm

Session 7
Concurrent A and B
Trainee Advocacy Highlighted Oral Abstract Sessions

Concurrent C
(Clinical Track Sessions)
AI, Wearables, and Oversight in Hypertension Care

3:30 – 4:30
Beyond the Cuff: Wearables and Next-Generation BP Monitoring Technologies

4:30 – 5:30
Smarter Hypertension: Harnessing AI for Detection and Management
5:30 pm to 7:00 pm

Poster Session 1 and Reception
Includes the TAC Poster Competition

 
7:00 pm to 8:00 pm

Networking Event: Mid-Career Mentorship Networking Roundtables
Friday, Oct. 9 Activities
Time Activity
8:00 am to 9:00 am

Session 8
Cognition and Dementia in Hypertension

Basic and immune mechanisms of cognitive impairment in hypertension
Daniela Carnevale, PhD

Cerebral small vessel disease and dementia in human hypertension
Rebecca Gottesman, MD, PhD
9:00 am to 13:00 am

Poster Session 2
And Breakfast Reception
10:30 am to 12:00 pm

Session 9
Concurrent Sessions A, B
(Oral Abstract Sessions)
12:00 pm to 1:00 pm TAC CHAMP Lunch Event
(By Invitation)
12:00 pm to 1:30 pm Lunch On Your Own
12:15 pm to 12:45 pm Sponsored Learning Studio
Idorsia Pharmaceuticals
1:00 pm to 1:30 pm Sponsored Learning Studio
Medtronic
1:30 pm to 3:00 pm

Session 10
Concurrents A and B
(Oral Abstract Sessions)

Concurrent C
(Clinical Track Session)
Aldosterone: Translating Evidence to Practice

3:00 pm to 3:30 pm Break
3:30 to 4:45 pm

Session 11
Annual Hypertension Awards Session
4:45 pm to 5:45 pm

Session 12
Lewis K. Dahl Memorial Lecture
Arthur C. Corcoran Memorial Lecture
7:00 pm to 10:00 pm

Trainee Advocacy Mixer Event
Saturday, Oct. 10 Activities
Time Activity
7:30 am to 8:30 am

Session 13
AHA/ACC Clinical Practice Guideline: Cardiovascular-Kidney-Metabolic Syndrome
8:30 am to 9:00 am

Session 14
Council on Kidney in Cardiovascular Disease Early Career Session
3 Trainee Featured Abstracts
8:00 am to 9:00 a.m. Session 14C (Concurrent)
(Clinical Track Session)
Measurement and Remote Monitoring: What Clinicians Need to Know
 9:00 am to 10:00 am

Session 15
Concurrent A, B
(Oral Abstract Sessions)

Concurrent C
(Clinical Track Sessions)
Making Hypertension Care Work in Real-World Clinics
10:00 am to 10:30 am Break 
10:30 am to 12:00 pm

Session 16
Concurrent A and B
Trainee Advocacy Highlighted Oral Abstract Sessions

Concurrent C
Hypertension Journal Cases
12:00 to 1:30 pm

Lunch On your Own
12:00 to 1:00 pm

Networking Event: Meet the Hypertension Editors
12:15 to 12:45 pm

Sponsored Learning Studio
Corcept Therapeutics
1:00 to 1:30 pm

Sponsored Learning Studio
Mineralys Therapeutics
1:30 pm to 3:00 pm

Session 17
Concurrent A and B
(Oral Abstract Sessions)

Concurrent C
(Clinical Track Session)
Early Life Origins and Lifecourse Tracking of Blood Pressure
3:00 pm to 3:30 pm  Break 
3:30 pm to 4:30 pm

Session 18
Council on Hypertension Mid-Career Award for Research Excellence Lecture
KCVD Mid-Career Achievement Award Lecture
4:30 pm to 5:30 pm

Session 19
Concurrent A and B
(Oral Abstract Sessions)

Concurrent C
(Clinical track Session)
Lifestyle and Non-Pharmalogic Implementation
5:45 pm to 6:15 pm

Session 20
Excellence Award for Hypertension Research
7:00 pm to 10:00 pm

Hypertension Council Gala Dinner

Sunday, Oct. 11 Activities
Time Activity
8:00 am to 9:30 am

Session 21
Circadian Regulation of Cardiometabolic Health

The effects of time-restricted feeding on cardiovascular disease in obesity
Jennifer Pollock, PhD

Key clinical research: Role of Circadian Regulation in Cardiometabolic Health and Disease Risk
Kristen Knutson, PhD

BMAL1, aldosterone, and sex differences in blood pressure regulation
Michelle Gumz, PhD
9:30 am to 10:00 am Break
10:00 am to 11:30 am

Session 22
Concurrent Sessions A and B
(Oral Abstract Presentations)

Concurrent C
(Clinical Track Session)
Nuanced Clinical Cases in Hypertension
11:30 am to 12:00 pm

Session 23
Closing Keynote Lecture
Thu Le, MD, FAHA
Immediate Past Chair, Council on Kidney in Cardiovascular Disease

About This Meeting

Hypertension 2026 Scientific Sessions is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.

This year's programming also includes:

  • Recent Advances sessions
  • Lectures on cutting-edge science, followed by oral abstract presentations
  • Clinical Track featuring sessions focused on topics of direct relevance to clinicians, clinician-based scientists, and primary care physicians, emphasizing practical application, evidence-based practice, and translational insights.
  • Oral abstract sessions highlighting Early Career oral abstract presentations
  • Networking sessions
  • Trainee Advocacy Committee (TAC) Poster session and competition
  • Award Lecture sessions

Learning Objectives

  1. Discuss recent advances and emerging experimental models in hypertension and kidney disease.
  2. Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive and kidney-related disorders.
  3. Describe new therapeutic options and technologies for patients with hypertension and kidney disease.
  4. Describe the most up-to-date clinical guideline recommendations for the prevention, diagnosis, and management of hypertension and kidney disease.